AU2016252555A1 - Methods of treating bacterial infections - Google Patents

Methods of treating bacterial infections Download PDF

Info

Publication number
AU2016252555A1
AU2016252555A1 AU2016252555A AU2016252555A AU2016252555A1 AU 2016252555 A1 AU2016252555 A1 AU 2016252555A1 AU 2016252555 A AU2016252555 A AU 2016252555A AU 2016252555 A AU2016252555 A AU 2016252555A AU 2016252555 A1 AU2016252555 A1 AU 2016252555A1
Authority
AU
Australia
Prior art keywords
meropenem
compound
pharmaceutically acceptable
acceptable salt
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2016252555A
Other languages
English (en)
Inventor
Michael N. Dudley
David C. Griffith
Olga Lomovskaya
Jeffrey S. Loutit
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Melinta Subsidiary Corp
Original Assignee
Melinta Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=57144340&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2016252555(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Melinta Therapeutics Inc filed Critical Melinta Therapeutics Inc
Publication of AU2016252555A1 publication Critical patent/AU2016252555A1/en
Assigned to MELINTA THERAPEUTICS, INC. reassignment MELINTA THERAPEUTICS, INC. Request for Assignment Assignors: REMPEX PHARMACEUTICALS, INC.
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2016252555A 2015-04-24 2016-04-20 Methods of treating bacterial infections Abandoned AU2016252555A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562152668P 2015-04-24 2015-04-24
US62/152,668 2015-04-24
PCT/US2016/028437 WO2016172208A1 (en) 2015-04-24 2016-04-20 Methods of treating bacterial infections

Publications (1)

Publication Number Publication Date
AU2016252555A1 true AU2016252555A1 (en) 2017-11-09

Family

ID=57144340

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2016252555A Abandoned AU2016252555A1 (en) 2015-04-24 2016-04-20 Methods of treating bacterial infections

Country Status (8)

Country Link
US (2) US20160339045A1 (OSRAM)
EP (1) EP3285776B1 (OSRAM)
JP (2) JP6945452B2 (OSRAM)
CN (2) CN112755039A (OSRAM)
AU (1) AU2016252555A1 (OSRAM)
CA (1) CA2982911C (OSRAM)
ES (1) ES2942329T3 (OSRAM)
WO (1) WO2016172208A1 (OSRAM)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE048859T2 (hu) 2010-08-10 2020-08-28 Rempex Pharmaceuticals Inc Gyûrûs bórsavészter származékok, eljárás elõállításukra, és terápiás alkalmazásuk
CA2894891A1 (en) 2013-01-04 2014-07-10 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
WO2015171398A1 (en) 2014-05-05 2015-11-12 Rempex Pharmaceuticals, Inc. Salts and polymorphs of cyclic boronic acid ester derivatives and therapeutic uses thereof
ES2750805T3 (es) 2014-05-05 2020-03-27 Rempex Pharmaceuticals Inc Síntesis de sales de boronato y usos de las mismas
EA201691988A1 (ru) 2014-05-19 2017-06-30 Ремпекс Фармасьютикалз, Инк. Производные бороновой кислоты и их терапевтическое применение
US10206937B2 (en) 2014-07-01 2019-02-19 Qpex Biopharma, Inc. Boronic acid derivatives and therapeutic uses thereof
WO2016081297A1 (en) 2014-11-18 2016-05-26 Rempex Pharmaceuticals, Inc. Cyclic boronic acid ester derivatives and therapeutic uses thereof
WO2016149393A1 (en) 2015-03-17 2016-09-22 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
AU2017290060B2 (en) 2016-06-30 2021-07-22 Qpex Biopharma, Inc Boronic acid derivatives and therapeutic uses thereof
DK3565551T3 (da) * 2017-01-09 2024-06-17 Melinta Therapeutics Inc Fremgangsmåder til behandling af bakterielle infektioner med en kombination af vaborbactam og meropenem
AU2018345317B2 (en) * 2017-10-03 2024-10-24 Melinta Therapeutics, Inc. Methods of treating bacterial infections
BR112020007138B1 (pt) 2017-10-11 2023-03-21 Qpex Biopharma, Inc Derivados de ácido borônico, métodos de síntese, composição farmacêutica e uso dos mesmos
EP3781576B1 (en) 2018-04-20 2024-06-12 Qpex Biopharma, Inc. Boronic acid derivatives and therapeutic uses thereof
CN116098993B (zh) * 2022-11-17 2024-10-25 中国农业科学院特产研究所 一种狐、貉肺炎三联灭活疫苗及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783443A (en) 1986-03-03 1988-11-08 The University Of Chicago Amino acyl cephalosporin derivatives
HUE048859T2 (hu) 2010-08-10 2020-08-28 Rempex Pharmaceuticals Inc Gyûrûs bórsavészter származékok, eljárás elõállításukra, és terápiás alkalmazásuk
US10561675B2 (en) * 2012-06-06 2020-02-18 Rempex Pharmaceuticals, Inc. Cyclic boronic acid ester derivatives and therapeutic uses thereof

Also Published As

Publication number Publication date
JP2018513188A (ja) 2018-05-24
CN107530364A (zh) 2018-01-02
CN112755039A (zh) 2021-05-07
EP3285776B1 (en) 2022-12-21
EP3285776A1 (en) 2018-02-28
CA2982911C (en) 2023-10-03
CA2982911A1 (en) 2016-10-27
US20160339045A1 (en) 2016-11-24
WO2016172208A1 (en) 2016-10-27
ES2942329T3 (es) 2023-05-31
JP6945452B2 (ja) 2021-10-06
JP7245289B2 (ja) 2023-03-23
EP3285776A4 (en) 2019-01-23
US20190105337A1 (en) 2019-04-11
JP2021143196A (ja) 2021-09-24
HK1249432A1 (en) 2018-11-02

Similar Documents

Publication Publication Date Title
US11007206B2 (en) Cyclic boronic acid ester derivatives and therapeutic uses thereof
EP3285776B1 (en) Dosage regimen of vaborbactam and meropenem for treating bacterial infections in subjects with reduced renal function
EP3139930B1 (en) Salts and polymorphs of cyclic boronic acid ester derivatives and therapeutic uses thereof
EP3849562B1 (en) Combination compositions comprising a beta-lactamase inhibitor
US12478606B2 (en) Methods of treating bacterial infections
HK1249432B (en) Dosage regimen of vaborbactam and meropenem for treating bacterial infections in subjects with reduced renal function
HK40051777A (en) Methods of treating bacterial infections
HK40097685A (en) Methods of treating bacterial infections with vaborbactam and meropenem
HK40018408A (en) Methods of treating bacterial infections with a combination of vaborbactam and meropenem
HK40018408B (en) Methods of treating bacterial infections with a combination of vaborbactam and meropenem
WO2014071155A1 (en) Therapeutic uses of tigemonam and carumonam
NZ795891A (en) Methods of treating bacterial infections

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: MELINTA THERAPEUTICS, INC.

Free format text: FORMER APPLICANT(S): REMPEX PHARMACEUTICALS, INC.

MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted